Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-01-23 @ 2:08 PM
Study NCT ID:
NCT00017394
Status:
COMPLETED
Last Update Posted:
2013-01-17
First Post:
2001-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: